Position in CPRX
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$15,091,220
+$2,489,954 QoQ
Shares Held
609,500
+12.9% QoQ
Ownership
0.498%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 49%
Shared 0%
None 51%
Common Shares in CPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026LSV ASSET MANAGEMENT holds $1,556,348,509 across 16 Biotechnology names. CPRX ranks #10 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
2,386,840 | $451,232,102 | |
| 2 | INCY |
Incyte Corp
|
3,920,056 | $368,955,670 | |
| 3 | EXEL |
Exelixis, Inc.
|
7,745,715 | $332,213,716 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
196,279 | $151,653,006 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
1,371,558 | $88,643,793 | |
| 6 | HRMY |
Harmony Biosciences Holdings, Inc.
|
2,025,143 | $56,724,255 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
884,800 | $49,982,352 | |
| 8 | RIGL |
Rigel Pharmaceuticals Inc
|
601,507 | $16,264,749 |
All Filings in CPRX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $15,091,220 | 609,500 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $12,601,266 | 539,900 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $10,882,280 | 552,400 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $12,536,090 | 577,700 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $17,067,198 | 703,802 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $16,218,577 | 777,124 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $18,912,321 | 951,324 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $13,536,711 | 873,900 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $14,282,240 | 896,000 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $20,688,067 | 1,230,700 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $14,504,589 | 1,240,769 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $13,274,271 | 987,669 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $15,880,324 | 957,800 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $18,924,960 | 1,017,471 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $43,551,293 | 3,394,489 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $28,248,035 | 4,029,677 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $30,700,124 | 3,703,272 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $27,432,507 | 4,052,069 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $27,876,436 | 5,259,705 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $24,381,817 | 4,240,316 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $6,503,497 | 1,410,737 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $4,987,077 | 1,493,137 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $4,734,883 | 1,594,237 | Shares | Sole | 2020-10-23 | |
| 2020-06-30 | $783,981 | 169,693 | Shares | Sole | 2020-08-05 | |
| No filing history on record for this holder in this stock. | ||||||